Pricing
  1. US-listed companies
  2. IDEXX LABORATORIES INC
  3. Financials
  4. Stockholders' equity

IDEXX LABORATORIES INC (IDXX)

Market cap
$45.8B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 20241,595+7.46%
Dec 31, 20231,485+143.87%
Dec 31, 2022609-11.78%
Dec 31, 2021690+9.04%
Dec 31, 2020633+255.85%
Dec 31, 2019178-2025.97%
Dec 31, 2018-9-82.85%
Dec 31, 2017-54-50.24%
Dec 31, 2016-108+28.83%
Dec 31, 2015-84-171.43%
Dec 31, 2014118-77.31%
Dec 31, 2013518-18.55%
Dec 31, 2012636+17.91%
Dec 31, 2011540-6.04%
Dec 31, 2010574

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat